New Abu Dhabi plant to manufacture COVID-19 vaccine from China's Sinopharm
- Country:
- United Arab Emirates
A new pharmaceutical plant in Abu Dhabi will start making a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).
The vaccine will be called Hayat-Vax when manufactured in the United Arab Emirates but is the same BiBP inactivated vaccine that has been administered in the UAE since it was approved by authorities in December.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- BiBP
- Chinese
- United Arab
- Abu Dhabi
- Sinopharm
Advertisement
ALSO READ
US State Secy Blinken speaks to Turkish, Chinese, Saudi counterparts on avoiding escalation in Middle East
Highest-level meeting between Chinese and North Korean officials in years sparks discussions on diplomatic relations
Chinese economy to moderate in 2024: ADB
Retired chair of Chinese state-owned Everbright Group indicted on bribery charges
Visiting Chinese trade official warns EU on greentech probe